The DOI matches its Crossref record; 243 of the 243 references it cites were found in a registry or an index.
COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective
Abstract
Curtis C. Harris; COMMENTARY: p53 Tumor suppressor gene: from the basic research laboratory to the clinic—an abridged historical perspective, Carcinogenesis, Vo
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–243 of 243
p53 dependent growth suppression by the c-Abl nuclear tyrosine kinase.
Goga, A., Liu, X., Hambuch, T. M., Senechal, K., Major, E., Berk, A. J., Witte, O. N., & Sawyers, C. L. (1995) · PubMed · Cited by 133
Inst., H. (1994) · Lung Cancer · doi:10.1016/0169-5002(94)90782-x · Cited by 132
́, J. B., Bartek, J. J., Lukáŝ, J., Vojtěšek, B., Stašková, Z., Rejthar, A., Kovařík, J., Midgley, C., & Lane, D. P. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910490209 · Cited by 132
ZANTEMA, A., Schrier, P. I., Davis-Olivier, A., van Laar, T., Vaessen, R. T. M. J., & van der Eb, A. J. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.11.3084 · Cited by 131
Reciprocal modulations between p53 and Tat of human immunodeficiency virus type 1.
Li, C. J., Wang, C., Friedman, D. J., & Pardee, A. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5461 · Cited by 131
de Fromentel, C. C., Chandrasekaran, K., May, P., May-Levin, F., Mouriesse, H., & Lemerle, J. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390211 · Cited by 131
Gerwin, B. I., Spillare, E. A., Forrester, K., Lehman, T. A., Kispert, J., Welsh, J. A., Pfeifer, A. M. A., Lechner, J. F., Baker, S. J., & Vogelstein, B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.2759 · Cited by 131
p53: A Cell Cycle Regulator Activated by DNA Damage
Selivanova, G., & Wiman, K. G. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60253-5 · Cited by 128
Immunologically Distinct p53 Molecules Generated by Alternative Splicing
Arai, N., Nomura, D., Yokota, K., Wolf, D., Brill, E., Shohat, O., & Rotter, V. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.9.3232 · Cited by 128
p53 mutations in lung cancers from non-smoking atomic-bomb survivors
Takeshima, Y., Bennett, W. P., Land, C., Harris, C. C., Takeshima, Y., Inai, K., Takeshima, Y., Seyama, T., Akiyama, M., Tokuoka, S., et al. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80087-x · Cited by 125
Self-citationChen, X., Farmer, G., Zhu, H., Prywes, R., & Prives, C. L. (1993) · Genes & Development · doi:10.1101/gad.7.10.1837 · Cited by 124
Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice.
Bouffler, S. D., Kemp, C. J., Balmain, A., & Cox, R. (1995) · PubMed · Cited by 121
Somatic p53 mutations in human breast carcinomas in an Icelandic population: a prognostic factor.
Thorlacius, S., Børresen‐Dale, A., & Eyfjörd, J. E. (1993) · PubMed · Cited by 119
Molecular cloning of a cDNA specific for the murine p53 cellular tumor antigen.
Oren, M., & Levine, A. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.1.56 · Cited by 119
The Tumor Suppressor p53 Regulates Its Own Transcription
Deffie, A. M., Wu, H., Reinke, V., & Lozano, G. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3415 · Cited by 115
A DNA binding domain is contained in the C-terminus ofwild typep53 protein
Foord, O., Bhattacharya, P., Reich, Z., & Rotter, V. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.19.5191 · Cited by 113
Wolf, D., & Rotter, V. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.7.1402 · Cited by 111
Tumor Suppressor p53 Mutations and Breast Cancer: A Critical Analysis
Ozbun, M. A., & Butel, J. S. (1995) · Advances in cancer research · doi:10.1016/s0065-230x(08)60252-3 · Cited by 103
Meyn, M. S., Strasfeld, L. M., & Allen, C. (1994) · International Journal of Radiation Biology · doi:10.1080/09553009414551971 · Cited by 101
Sj, U., Mercer, W. E., & Appella, E. (1992) · PubMed · Cited by 99
Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes
Mercer, W. E., & Baserga, R. (1985) · Experimental Cell Research · doi:10.1016/0014-4827(85)90233-2 · Cited by 92
Repression of the basal c-fos promoter by wild-type p53
Kley, N., Chung, R. Y., Fay, S., Loeffler, J., & Seizinger, B. R. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.15.4083 · Cited by 90
Es, H., Picksley, S. M., & Kh, V. (1994) · PubMed · Cited by 88
Expression of the normal p53 gene induces differentiation of K562 cells.
Feinstein, E., Gale, R. P., Reed, J., & Canaani, E. (1992) · PubMed · Cited by 83
Isolation of a Full-Length Mouse cDNA Clone Coding for an Immunologically Distinct p53 Molecule
Wolf, D., Harris, N., Goldfinger, N., & Rotter, V. (1985) · Molecular and Cellular Biology · doi:10.1128/mcb.5.1.127 · Cited by 83
Rotter, V., Boss, M. A., & Baltimore, D. (1981) · Journal of Virology · doi:10.1128/jvi.38.1.336-346.1981 · Cited by 82
Shin, T. H., Paterson, A. J., & Kudlow, J. E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4694 · Cited by 78
Ishioka, C., Englert, C., Winge, P., Yan, Y., Engelstein, M., & Friend, S. H. (1995) · PubMed · Cited by 68
Evans, M. K., Taffe, B. G., Harris, C. C., & Bohr, V. A. (1993) · PubMed · Cited by 64
Self-citationp53 Increases Experimental Metastatic Capacity of Murine Carcinoma Cells
Pohl, J., Goldfinger, N., Radler‐Pohl, A., Rotter, V., & Schirrmacher, V. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.5.2078 · Cited by 62
Milner, J. (1991) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1991.0100 · Cited by 62
Woodworth, C. D., Wang, H., Simpson, S., Álvarez-Salas, L. M., & Notario, V. (1993) · PubMed · Cited by 62
Zambetti, G. P., Olson, D., Labow, M., & Levine, A. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.9.3952 · Cited by 61
Jamal, S., & Ziff, E. B. (1995) · PubMed · Cited by 59
Alternatively spliced p53 RNA in transformed and normal cells of different tissue types
Han, K., & Kulesz-Martin, M. F. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.8.1979 · Cited by 57
Delphin, C., & Baudier, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43919-1 · Cited by 48
Rotter, V., & Prokocimer, M. (1991) · Advances in cancer research · doi:10.1016/s0065-230x(08)61001-5 · Cited by 44
Ford, J. M., Lommel, L., & Hanawalt, P. C. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940100208 · Cited by 42
Isolation and Characterization of DNA Sequences That Are Specifically Bound by Wild-Type p53 Protein
Foord, O., Navot, N., & Rotter, V. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.3.1378 · Cited by 37
Induction of p53 in mouse cells decreases mutagenesis by UV radiation
Yuan, J., Yeasky, T. M., Havre, P. A., & Glazer, P. M. (1995) · Carcinogenesis · doi:10.1093/carcin/16.10.2295 · Cited by 37
Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression
Crook, T., Fisher, C., & Vousden, K. H. (1991) · Journal of Virology · doi:10.1128/jvi.65.1.505-510.1991 · Cited by 32
Elkind, N. B., Goldfinger, N., & Rotter, V. (1995) · PubMed · Cited by 11
(1988) · PubMed
Cited by
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
An Information-Intensive Approach to the Molecular Pharmacology of Cancer
Weinstein, J. N., Myers, T. G., O'Connor, P. M., Friend, S. H., Fornace, A. J., Kohn, K. W., Fojo, T., Bates, S. E., Rubinstein, L. V., Anderson, N. L., et al. (1997) · Science · doi:10.1126/science.275.5298.343 · Cited by 1,183
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Rules for Making Human Tumor Cells
Hahn, W. C., & Weinberg, R. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmra021902 · Cited by 951
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Metadata
- Authors
- Harris, C. C.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 1996
- Volume
- 17
- Issue
- 6
- Pages
- 1187-1198
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W1983832776
- Cited by
- 285
- References
- 243
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.